HIV vaccine (Gritstone Oncology/Gilead Sciences)

N/A

Report date: 2025/05/14 11:14:22

Base Information

Drug NameHIV vaccine (Gritstone Oncology/Gilead Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine > self-amplifying mRNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGritstone Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncGritstone Bio Inc
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A